chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Arthritis, Fatigue, Loss of personal independence in daily activities, Musculoskeletal stiffness
Clinical narrative: From office visit note dated 2/14/23: still struggling with arthritis and fatigue.  This started after her last COVID booster and she still having a lot of stiffness in her hands and her right shoulder along with significant fatigue.  All of this is keeping her from achieving her previous level of function
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: none
Age: 0.33
Sex: M
Vaccine: DTAPHEPBIP
Symptoms: Pyrexia
Clinical narrative: fever (reported by mom as high as 105.2 F). Exam next day 3/2/23 NORMAL
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Anaemia, Atrial fibrillation, Dizziness, Dyspnoea, Palpitations
Clinical narrative: Hospitalized 8/4/22-8/6/22 SOB, tachycardia, palpitation, afib, dizziness, PNA, anemia,
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Pneumonia, Tachycardia
Clinical narrative: Hospitalized 8/4/22-8/6/22 SOB, tachycardia, palpitation, afib, dizziness, PNA, anemia,
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Back pain, Dizziness, Fatigue, Headache, Nausea
Clinical narrative: Severe pain in arm, back ache, headache, low grade fever, dizziness, nausea, fatigue
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Severe pain in arm, back ache, headache, low grade fever, dizziness, nausea, fatigue
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Agitation, Asthenia, COVID-19, Confusional state, Cough
Clinical narrative: 3RD DOSE PFIZER COVID VACCINE GIVEN 9/8/21, LOT # NOT AVAILABLE 4TH DOSE CORMIRNATY COVID VACCINE GIVEN 5/25/22, #FK9894 9/3/22 pt had a positive COVID test; 9/6/22 to hospital with fever, cough, SOB, weaker past 3 days; O2 supplementation; worsening confusion and seizure like activity while infusing Remdesivir, dc'd medication; continued with Dexamethasone; worsening respiratory failure; ABX; increased agitation and confusion; on high flow NC O2; transitioned to comfort care and pt passed away in the hospital
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Dyspnoea, Pyrexia, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: 3RD DOSE PFIZER COVID VACCINE GIVEN 9/8/21, LOT # NOT AVAILABLE 4TH DOSE CORMIRNATY COVID VACCINE GIVEN 5/25/22, #FK9894 9/3/22 pt had a positive COVID test; 9/6/22 to hospital with fever, cough, SOB, weaker past 3 days; O2 supplementation; worsening confusion and seizure like activity while infusing Remdesivir, dc'd medication; continued with Dexamethasone; worsening respiratory failure; ABX; increased agitation and confusion; on high flow NC O2; transitioned to comfort care and pt passed away in the hospital
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Seizure like phenomena
Clinical narrative: 3RD DOSE PFIZER COVID VACCINE GIVEN 9/8/21, LOT # NOT AVAILABLE 4TH DOSE CORMIRNATY COVID VACCINE GIVEN 5/25/22, #FK9894 9/3/22 pt had a positive COVID test; 9/6/22 to hospital with fever, cough, SOB, weaker past 3 days; O2 supplementation; worsening confusion and seizure like activity while infusing Remdesivir, dc'd medication; continued with Dexamethasone; worsening respiratory failure; ABX; increased agitation and confusion; on high flow NC O2; transitioned to comfort care and pt passed away in the hospital
Age: 46.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient given bivalent 50 mcg  instead of monovalent 00 mcg for 2nd dose in series. Attempting to contact patient to schedule monovalent dose.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Arthralgia, Back pain, Blood test, Chest X-ray
Clinical narrative: I got a blood clot in my right lung. Symptoms started with extreme pain in side and back. Then, started up into my shoulder and neck as well. Pain became intolerable so we went to the ER. I had to be admitted overnight. I am now being treated with blood thinners for a few months.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram thorax abnormal, Flank pain, Neck pain, Pulmonary thrombosis, Scan with contrast abnormal
Clinical narrative: I got a blood clot in my right lung. Symptoms started with extreme pain in side and back. Then, started up into my shoulder and neck as well. Pain became intolerable so we went to the ER. I had to be admitted overnight. I am now being treated with blood thinners for a few months.
Age: 59.0
Sex: F
Vaccine: VARZOS
Symptoms: Device issue, Device leakage, Exposure via skin contact
Clinical narrative: During administration of the vaccine into the patient's shoulder, the needle cap detached from the syringe as the syringe plunger was being pressed in and the vaccine spilled onto the patient's shoulder instead of entering the patient's body. Called CDC and revaccination was recommended according to their guidelines.
Age: 37.0
Sex: F
Vaccine: HEPA, HIBV
Symptoms: Arthralgia, Injection site pain
Clinical narrative: On 03/01/2023 - Hib vaccine given first in right deltoid, then Hep. A given in left deltoid. After Hep. A was given, patient reported to writer/vaccinator that she "felt that one." Writer/vaccinator stated to patient that the Hep. A vaccine is 1.0ml, compared to the Hib vaccine which is 0.5ml, which may be attributing to the immediate sensation felt. Patient stated she was feeling well and was escorted to the waiting room by writer/vaccinator. On 03/02/2023 - Patient called agency and reported that she is having pain in her left shoulder and is having trouble moving her left arm out to the side. Patient stated she was in contact with her primary care doctor, who will be prescribing a steroid for her. It was explained to patient that a report will be sent in regarding these side effects, and agency will be following up with her - Patient stated understanding.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram abnormal, Induration, Lymph node pain, Lymphadenitis, Lymphadenopathy
Clinical narrative: Initially after a day or so my Lymph node and surrounding tissue/area in left armpit/axilla swelled to a very large size and was very tender. After a while the Lymph node seemed to have shrunk by the inflammation/swelling and pain in the armpit/axilla remained.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Magnetic resonance imaging normal, Shoulder injury related to vaccine administration, Skin hypertrophy, X-ray limb normal
Clinical narrative: Initially after a day or so my Lymph node and surrounding tissue/area in left armpit/axilla swelled to a very large size and was very tender. After a while the Lymph node seemed to have shrunk by the inflammation/swelling and pain in the armpit/axilla remained.
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product administered to patient of inappropriate age
Clinical narrative: Adult dose was administered to pedi patient.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Patient was administered a covid monovalent vaccine instead of the bivalent booster. Patient has had no symptoms of any kind in regard to this.
Age: 13.0
Sex: F
Vaccine: COVID19, HEPA, HPV9, IPV, MMR, MNQ, TDAP, VARCEL
Symptoms: Pruritus, Rash
Clinical narrative: Client states itching and rash on chest/neck in the waiting room approx. 5 min after receiving vaccines. Pt assessment done. 50 MG of Benadryl was given within a few min of patient reporting symptoms. Patient was assessed for half an hour. After a half hour patient self reported feeling better via translator and left the clinic.
Age: 81.0
Sex: F
Vaccine: COVID19-2
Symptoms: Cough
Clinical narrative: Cough began 2/24/23. Transferred to a local hospital from another HCF on 2/28/23. Treatment includes admission, medication and assessment.
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Adult dose given to pedi patient.
Age: 0.92
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Conjunctivitis, Cough, Decreased appetite, Nasal congestion
Clinical narrative: He got COVID-19 on 09/22/2023 fever, cough, runny nose, stuffiness.  We had a virtual visit with provider. Then on 11/23/2022 he had mild fever, runny nose. We had a virtual appointment again with provider but did not test positive for COVID-19. Then again on 02/02/2023 he tested positive for COVID-19. He had a high fever of 103.5, lost of appetite.  Also he had conjunctivitis in both eyes. Did another virtual visit and provider prescribed ibuprofen.
Age: 0.92
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: He got COVID-19 on 09/22/2023 fever, cough, runny nose, stuffiness.  We had a virtual visit with provider. Then on 11/23/2022 he had mild fever, runny nose. We had a virtual appointment again with provider but did not test positive for COVID-19. Then again on 02/02/2023 he tested positive for COVID-19. He had a high fever of 103.5, lost of appetite.  Also he had conjunctivitis in both eyes. Did another virtual visit and provider prescribed ibuprofen.
Age: 89.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Chest tube insertion, Chest tube removal, Dyspnoea, Encephalopathy
Clinical narrative: Discharge summary "Patient is a 89 YO male history of bronchiectasis, prior Pseudomonas empyema, Parkinson's disease presented with dyspnea. He was found severely hypoxic. Labs reveal COVID +.    During his stay, he received 5 days of Remdesivir and steroids for COVID treatment. He was initially placed on Rocephin and Doxycycline. His hospitalization was complicated by worsening respiratory status with concern for rapidly progressive left sided loculated effusion with concern for empyema. Pulmonary and IR were consulted and patient underwent left sided chest tube placement. ID was consulted who transitioned patient to Cefepime and Flagyl for better anaerobic coverage. He received TPA/Dornase instillation as well. His hospitalization was further complicated by worsening encephalopathy and leukocytosis despite medical management. Goals of care discussion were done with assistance from Palliative and Hospice care team. Family (son and wife) has elected to transition patient to Comfort care with plans to discharge back to prior living arrangements with Hospice team. Chest tube removed morning of day of discharge as requested by family. "
Age: 89.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Hypoxia, Leukocytosis, Respiratory disorder, SARS-CoV-2 test positive
Clinical narrative: Discharge summary "Patient is a 89 YO male history of bronchiectasis, prior Pseudomonas empyema, Parkinson's disease presented with dyspnea. He was found severely hypoxic. Labs reveal COVID +.    During his stay, he received 5 days of Remdesivir and steroids for COVID treatment. He was initially placed on Rocephin and Doxycycline. His hospitalization was complicated by worsening respiratory status with concern for rapidly progressive left sided loculated effusion with concern for empyema. Pulmonary and IR were consulted and patient underwent left sided chest tube placement. ID was consulted who transitioned patient to Cefepime and Flagyl for better anaerobic coverage. He received TPA/Dornase instillation as well. His hospitalization was further complicated by worsening encephalopathy and leukocytosis despite medical management. Goals of care discussion were done with assistance from Palliative and Hospice care team. Family (son and wife) has elected to transition patient to Comfort care with plans to discharge back to prior living arrangements with Hospice team. Chest tube removed morning of day of discharge as requested by family. "
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood alkaline phosphatase increased, Blood lactic acid increased, COVID-19, Chronic obstructive pulmonary disease, Condition aggravated
Clinical narrative: Discharge summary "Patient is a 60-year-old female with a past medical history of oxygen-dependent chronic obstructive pulmonary disease (3-4 L), anxiety, bipolar, chronic pain who presents with shortness of breath.  Found to have chronic obstructive pulmonary disease exacerbation secondary to acute COVID infection.  Patient was treated with DuoNebs, Decadron, remdesivir.  On the day of discharge patient was back on her 3-4 L home oxygen and felt back to her baseline.  She was okay with getting a final dose of remdesivir and then discontinuing the course.  She will complete a total of 10 days of Decadron at home.  No antibiotics were given as I felt the cause of her chronic obstructive pulmonary disease exacerbation was likely the COVID infection.  She was given Levaquin in the hospital in case there is a superimposed bacterial component, but did not tolerate it well and due to allergies there are limited other options."
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dyspnoea, Influenza, Obesity, SARS-CoV-2 test positive, Spinal osteoarthritis
Clinical narrative: Discharge summary "Patient is a 60-year-old female with a past medical history of oxygen-dependent chronic obstructive pulmonary disease (3-4 L), anxiety, bipolar, chronic pain who presents with shortness of breath.  Found to have chronic obstructive pulmonary disease exacerbation secondary to acute COVID infection.  Patient was treated with DuoNebs, Decadron, remdesivir.  On the day of discharge patient was back on her 3-4 L home oxygen and felt back to her baseline.  She was okay with getting a final dose of remdesivir and then discontinuing the course.  She will complete a total of 10 days of Decadron at home.  No antibiotics were given as I felt the cause of her chronic obstructive pulmonary disease exacerbation was likely the COVID infection.  She was given Levaquin in the hospital in case there is a superimposed bacterial component, but did not tolerate it well and due to allergies there are limited other options."
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19, Death, Fall, SARS-CoV-2 test positive
Clinical narrative: 3RD DOSE COVID VACCINE, PFIZER, GIVEN 11/18/21, #FG3527; 4TH DOSE COVID VACCINE, PFIZER, GIVEN 4/26/22, #FM9992; 8/28/22 pt brought to hospital after a fall in assisted living facility; found to be positive for COVID; asymptomatic; no O2 supplementation needed; dc'd to Health and Rehab Center on 8/30/22 where he passed away 2 wks later
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Atrial fibrillation, COVID-19, Confusional state, Death
Clinical narrative: 9/7/22 pt found minimally responsive by family; EMS brought to ED with low BP; had fallen in last few days; slightly confused; found to be positive for COVID; AKI; Atrial Fibrillation with RVR; not hypoxic on RA; Atrial Fibrillation treated with medication; dc'd to home in fair condition on 9/9/22; pt passed away at home
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Hyporesponsive to stimuli, Hypotension, SARS-CoV-2 test positive
Clinical narrative: 9/7/22 pt found minimally responsive by family; EMS brought to ED with low BP; had fallen in last few days; slightly confused; found to be positive for COVID; AKI; Atrial Fibrillation with RVR; not hypoxic on RA; Atrial Fibrillation treated with medication; dc'd to home in fair condition on 9/9/22; pt passed away at home
Age: 16.0
Sex: M
Vaccine: COVID19-2, FLU4, TYP, YF
Symptoms: Allergy to vaccine, Cough, Hypersensitivity, Pruritus, Rash
Clinical narrative: Per notes from medical provider: ?HPI Patient comes in for evaluation of rash. Onset of rash 315. Had just received immunizations including COVID booster, yellow fever, typhoid and flu vaccine 215. Rash is itchy and red. Rash is generalized and spread to his chest back arms neck abdomen and legs. Rash is itchy. States his throat feels irritated and scratchy. States he did have nausea but that is better. Denies chest pain or airway closure. States he did take some ibuprofen. He denies body aches, headache, syncope. Denies history of allergic reactions to vaccines in the past. Mother accompanies patient here in the clinic. Allergic Reaction This is a new problem. The current episode started today. The problem occurs daily. The problem has been rapidly worsening since onset. Associated symptoms include coughing (dry) and a rash. Pertinent negatives include no abdominal pain, chest pain, eye itching, eye redness, stridor, trouble swallowing, vomiting or wheezing. There is no history of food allergies. Encounter Diagnoses  -T80.69XA Allergic reaction to vaccine -L50.9 Hives -L29.9 Pruritus Patient was seen today for allergic reaction. Diagnoses and all orders for this visit: Allergic reaction to vaccine - methylPREDNISolone sodium succinate(PF) (SOLU-MEDROL) injection 40 mg - diphenhyrAMINE (Benadryl) capsule 25 mg - famotidine (PF) (Pepcid) injection 10 mg - EPINEPHrine (EPIPEN) 0.3 mg/0.3 ML Atln; Inject 0.3 mLs (0.3 mg total) into muscle 1 (one) time a day as needed (anaphylaxis). Or subcutaneous. May repeat does x 1 after 5-15 min Educated mother she can give another Benadryl 25 mg if needed. Educational handout given on medications. Educated on EpiPen. If airway closure did educate on administration of EpiPen and to go to the ER immediately or call 911. Mother in agreement with plan and verbalized understanding. Hives - methylPREDNISolone sodium succinate(PF) (SOLU-MEDROL) injection 40 mg - diphenhyrAMINE (Benadryl) capsule 25 mg - famotidine (PF) (Pepcid) injection 10 mg - EPINEPHrine (EPIPEN) 0.3 mg/0.3 ML Atln; Inject 0.3 mLs (0.3 mg total) into muscle 1 (one) time a day as needed (anaphylaxis). Or subcutaneous. May repeat does x 1 after 5-15 min Pruritus - methylPREDNISolone sodium succinate(PF) (SOLU-MEDROL) injection 40 mg - diphenhyrAMINE (Benadryl) capsule 25 mg - famotidine (PF) (Pepcid) injection 10 mg - EPINEPHrine (EPIPEN) 0.3 mg/0.3 ML Atln; Inject 0.3 mLs (0.3 mg total) into muscle 1 (one) time a day as needed (anaphylaxis). Or subcutaneous. May repeat does x 1 after 5-15 min?
Age: 16.0
Sex: M
Vaccine: COVID19-2, FLU4, TYP, YF
Symptoms: Rash erythematous, Rash pruritic, Throat irritation, Urticaria
Clinical narrative: Per notes from medical provider: ?HPI Patient comes in for evaluation of rash. Onset of rash 315. Had just received immunizations including COVID booster, yellow fever, typhoid and flu vaccine 215. Rash is itchy and red. Rash is generalized and spread to his chest back arms neck abdomen and legs. Rash is itchy. States his throat feels irritated and scratchy. States he did have nausea but that is better. Denies chest pain or airway closure. States he did take some ibuprofen. He denies body aches, headache, syncope. Denies history of allergic reactions to vaccines in the past. Mother accompanies patient here in the clinic. Allergic Reaction This is a new problem. The current episode started today. The problem occurs daily. The problem has been rapidly worsening since onset. Associated symptoms include coughing (dry) and a rash. Pertinent negatives include no abdominal pain, chest pain, eye itching, eye redness, stridor, trouble swallowing, vomiting or wheezing. There is no history of food allergies. Encounter Diagnoses  -T80.69XA Allergic reaction to vaccine -L50.9 Hives -L29.9 Pruritus Patient was seen today for allergic reaction. Diagnoses and all orders for this visit: Allergic reaction to vaccine - methylPREDNISolone sodium succinate(PF) (SOLU-MEDROL) injection 40 mg - diphenhyrAMINE (Benadryl) capsule 25 mg - famotidine (PF) (Pepcid) injection 10 mg - EPINEPHrine (EPIPEN) 0.3 mg/0.3 ML Atln; Inject 0.3 mLs (0.3 mg total) into muscle 1 (one) time a day as needed (anaphylaxis). Or subcutaneous. May repeat does x 1 after 5-15 min Educated mother she can give another Benadryl 25 mg if needed. Educational handout given on medications. Educated on EpiPen. If airway closure did educate on administration of EpiPen and to go to the ER immediately or call 911. Mother in agreement with plan and verbalized understanding. Hives - methylPREDNISolone sodium succinate(PF) (SOLU-MEDROL) injection 40 mg - diphenhyrAMINE (Benadryl) capsule 25 mg - famotidine (PF) (Pepcid) injection 10 mg - EPINEPHrine (EPIPEN) 0.3 mg/0.3 ML Atln; Inject 0.3 mLs (0.3 mg total) into muscle 1 (one) time a day as needed (anaphylaxis). Or subcutaneous. May repeat does x 1 after 5-15 min Pruritus - methylPREDNISolone sodium succinate(PF) (SOLU-MEDROL) injection 40 mg - diphenhyrAMINE (Benadryl) capsule 25 mg - famotidine (PF) (Pepcid) injection 10 mg - EPINEPHrine (EPIPEN) 0.3 mg/0.3 ML Atln; Inject 0.3 mLs (0.3 mg total) into muscle 1 (one) time a day as needed (anaphylaxis). Or subcutaneous. May repeat does x 1 after 5-15 min?
Age: 91.0
Sex: F
Vaccine: COVID19-2
Symptoms: Burning sensation, Cellulitis, Ear inflammation, Ear pain, Erythema
Clinical narrative: She got her vaccine, does not remember anything other than a sore arm or a bad reaction itself at the time.  About 2 weeks later when she returned home she noticed that her head was really itchy and burning.  Her ear got real red, inflamed and hurt.  She went to the ER and he asked her if she had had shingles before and dismissed it.  He said that she had cellulitis.  She went to her message therapist who informed her that she had shingles.  She did not take anything for the reaction other than her vitamins and Tylenol.  The nodules went away in about 3-4 weeks.  She occasionally has a little ache on her scalp, kind of an aftermath of it.  They were mainly on the left side of her scalp
Age: 91.0
Sex: F
Vaccine: COVID19-2
Symptoms: Herpes zoster, Nodule, Pain in extremity, Pain of skin, Pruritus
Clinical narrative: She got her vaccine, does not remember anything other than a sore arm or a bad reaction itself at the time.  About 2 weeks later when she returned home she noticed that her head was really itchy and burning.  Her ear got real red, inflamed and hurt.  She went to the ER and he asked her if she had had shingles before and dismissed it.  He said that she had cellulitis.  She went to her message therapist who informed her that she had shingles.  She did not take anything for the reaction other than her vitamins and Tylenol.  The nodules went away in about 3-4 weeks.  She occasionally has a little ache on her scalp, kind of an aftermath of it.  They were mainly on the left side of her scalp
Age: 1.0
Sex: F
Vaccine: DTAP, FLU4, HIBV, MMR, PNC13
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: Infanrix vaccine administered prior to four to six month interval. Administered at 3mo, 1weeks. No adverse reaction from patient.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Janssen 4/6/21 Lot# 042A21A;  Janssen 11/18/21 Lot# 213D21A
Age: 3.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: wrong dose was given to the child
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Fatigue, SARS-CoV-2 test positive
Clinical narrative: breakthrough infection with positive covid test on 3/1. Presented with symptoms of cough, SOB and fatigue on 2/21. Tested negative on  2/21. However due to persistent cough she was re-tested on 3/1 and was positive
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccine breakthrough infection
Clinical narrative: breakthrough infection with positive covid test on 3/1. Presented with symptoms of cough, SOB and fatigue on 2/21. Tested negative on  2/21. However due to persistent cough she was re-tested on 3/1 and was positive
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines  Moderna 3/15/21 Lot# 010A21A;  Moderna 04/12/2021 Lot# 002B21A
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Moderna 05/07/2021 Lot# 002C21A;  Moderna 6/4/21 Lot# 033C21A
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Pfizer 4/2/21 Lot# ER8730;  Pfizer 4/23/21 LOt# Ew0162
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Moderna 2/27/21 Lot# 010A21A;  Moderna 3/27/21 Lot# 018B21A;
Age: 5.0
Sex: M
Vaccine: DTAP
Symptoms: Injection site swelling, Pyrexia, Vaccination site erythema, Vaccination site induration, Vaccination site nodule
Clinical narrative: Indurated nodule underneath vaccination site within deltoid muscle; 2"x2" with warmth, erythema and localized swelling of his entire upper arm. Fever of 103 3-4 days after vaccination for 8 hours. Nodule remains and is still palpable after nearly one month, however it is improved and is now 1/2" x 1" in size.
Age: 5.0
Sex: M
Vaccine: DTAP
Symptoms: Vaccination site warmth
Clinical narrative: Indurated nodule underneath vaccination site within deltoid muscle; 2"x2" with warmth, erythema and localized swelling of his entire upper arm. Fever of 103 3-4 days after vaccination for 8 hours. Nodule remains and is still palpable after nearly one month, however it is improved and is now 1/2" x 1" in size.
Age: 18.0
Sex: M
Vaccine: MMRV
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: no symptoms
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines  Moderna 4/14/21 Lot# 043B21A;  Moderna 5/12/21 Lot# 044B21A; Pfizer 12/15/21 Lot# 32030BD
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Pfizer 2/21/21 Lot# EL9267;  Pfizer 3/14/21 Lot# En6200;  Pfizer 9/22/21 Lot# EW0179
Age: 11.0
Sex: F
Vaccine: COVID19, DTAP, FLU4, HPV9, MNQ
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient received a DTaP vaccine. No adverse symptoms. Child is doing well.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Cough, Decreased appetite, Dehydration, Diarrhoea
Clinical narrative: Hospitalized 8/4/22-8/10/22 weakness, fatigue, decreased appetite, cough, diarrhea, dehydration, hypoxia,
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Hypoxia
Clinical narrative: Hospitalized 8/4/22-8/10/22 weakness, fatigue, decreased appetite, cough, diarrhea, dehydration, hypoxia,
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth, Peripheral swelling, Pyrexia
Clinical narrative: Pt received Shingrix on 2/24/2023, woke up with fever and stayed in bed on 2/25/2023. fever subsided. pt presented to pharmacy on 3/2/2023 with injection site swelling, redness, heat and some slight swelling under the left arm. explained to pt these we most likely just typical injection site reactions
Age: 58.0
Sex: F
Vaccine: VARZOS
Symptoms: Nodule, Pain
Clinical narrative: patients describes having a painful  knot on the neck/shoulder area of the same side of injection
Age: 8.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse outcomes reported at time of filing report. Reporting d/t administration error. Administered 3 days past expiration date.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Amenorrhoea, Blood test normal, COVID-19, Pruritus, Swelling
Clinical narrative: Hives/itching/significant swelling that started several weeks after the vaccine and has continued intermittently for the past 1.5 years; while I didn't initially connect this to the vaccine, it flared significantly after receiving a booster (within hours) (Pfizer FJ8762, administered 1/6/22), and again (and worse than ever) when I contracted COVID in May 2022, such that there seems to be a clear connection. OTC allergy medication and topical steroids reduce symptoms but don't prevent flares.   I also experienced ~4 months of amenorrhea after receiving the 2nd shot, but that resolved and did not recur.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Hives/itching/significant swelling that started several weeks after the vaccine and has continued intermittently for the past 1.5 years; while I didn't initially connect this to the vaccine, it flared significantly after receiving a booster (within hours) (Pfizer FJ8762, administered 1/6/22), and again (and worse than ever) when I contracted COVID in May 2022, such that there seems to be a clear connection. OTC allergy medication and topical steroids reduce symptoms but don't prevent flares.   I also experienced ~4 months of amenorrhea after receiving the 2nd shot, but that resolved and did not recur.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines pfizer 2/19/21 Lot# El9267;  Pfizer 3/12/21 LOt# En 6205;  12/28/21 Lot FJ1620 Pfizer
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, Pain, Pyrexia, Respiratory tract congestion
Clinical narrative: Hospitalized 8/8/22-8/12/22 SOB, congestion, cough, dyspnea, fever, body aches,
Age: 9.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product administration error
Clinical narrative: No adverse outcomes reported at time of filing report. Reporting d/t administration error. Administered 3 days past expiration date.
Age: 1.58
Sex: F
Vaccine: HEPA
Symptoms: Circumstance or information capable of leading to medication error, Product leakage, Underdose
Clinical narrative: Patient was moving their leg around and the vaccine was not fully given to patient.  Most of the vaccine spirted outside of the site because of the patient moving their leg so much.  Parent didn't have a good grip on the patient. Vaccine was not given fully.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Pfizer 9/25/21 Lot# Ew0169;  Pfizer 10/16/21 Lot# Ew0179
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product administration error
Clinical narrative: No adverse outcomes reported to the HD at time of filing report. Reporting d/t administration error. Administered 3 days past expiration date.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Moderna 3/17/21 Lot# 002B21A;  Moderna 4/13/21 Lot# 025B21A;  Moderna 1/26/22 Lot# 013H21B
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Cough, Fatigue, Malaise, Myalgia
Clinical narrative: Patient with history of CKD stage 3 and diabetes. He was seen in the ED on 12/10/22, and reported symptom onset on 12/1/22 with muscle aches, fatigue, cough, and nausea. He took a home COVID-19 test the day prior (12/9) which was positive. A COVID PCR test was also done in the ED which resulted positive. Ultimately he was admitted to the hospital 12/10/22 - 12/11/22 for generalized malaise secondary to COVID. Patient has received the primary COVID vaccine series and one booster.
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Nausea, SARS-CoV-2 test positive
Clinical narrative: Patient with history of CKD stage 3 and diabetes. He was seen in the ED on 12/10/22, and reported symptom onset on 12/1/22 with muscle aches, fatigue, cough, and nausea. He took a home COVID-19 test the day prior (12/9) which was positive. A COVID PCR test was also done in the ED which resulted positive. Ultimately he was admitted to the hospital 12/10/22 - 12/11/22 for generalized malaise secondary to COVID. Patient has received the primary COVID vaccine series and one booster.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Moderna 12/31/20 Lot# 025J20A;  Moderna 1/25/21 Lot# 012L20A
Age: 8.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Product administration error, Pyrexia
Clinical narrative: Grandmother reported low grade fever, poor appetite at time of filing report. Reporting d/t administration error. Administered 3 days past expiration date.
Age: 66.0
Sex: M
Vaccine: COVID19-2
Symptoms: Muscle spasms, Myalgia
Clinical narrative: since the injection my left upper arm and shoulder have had a muscle pain or cramp. The odd thing is my wife has had the same problem, we both received the same product in the left arm. I have been doing exercises and stretches and can work the pain down but this is still staying with us.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, Headache, Hypoxia, Pneumonia
Clinical narrative: Hospitalized 8/9/22-8/11/22 SOB, HA, dyspnea, cough, tachypnic, hypoxia, PNA, fever,
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Tachypnoea
Clinical narrative: Hospitalized 8/9/22-8/11/22 SOB, HA, dyspnea, cough, tachypnic, hypoxia, PNA, fever,
Age: 70.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration. Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below. The patient returned on 2/27/23 to be revaccinated; he received Moderna  Lot# 066H22A Exp: 3/8/23.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Form would change his DOB. Patient's DOB. Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.  Patient called on 2/22/23 at 11:29 am and left a message stating" I received a letter in the mail about an error in recording the expiration date. I just want to know if I need to receive another vaccine."; I, called the patient back at 12:18 pm on his cell phone as requested and left a voicemail for a return call. The patient called back at 12:49 pm; he was informed of the manufacturer's response; he verbalized understanding and gratitude; he also declines revaccination at this time.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Patient with history of quadriplegia secondary to C6 spinal cord injury. She was brought to the ED by EMS on 12/10 for evaluation of fever, cough, and shortness of breath for the past two days.  Additionally, patient reported concern that she is not getting adequate care and help at home. A COVID-19 PCR test done in the ED on that day resulted positive. Ultimately patient admitted as an observation for COVID-19 infection and concern for inadequate care at present living situation. During admission, patient was afebrile, hemodynamically stable, and satting well on room air. She was admitted 12/10/22 - 12/31/22. Per the discharge summary, her COVID-19 infection resolved during her admission.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 4 vaccines Moderna 2/12/21 Lot# 015M20A;  Moderna 3/12/21 Lot# 010A21A;  Moderna11/1921 Lot# 077C21B; 5/25/22 Lot# 059M21A Moderna
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19-2
Symptoms: Acute myocardial infarction, Acute respiratory failure, Asthenia, Atrial fibrillation, COVID-19
Clinical narrative: Patient was brought to the ED by EMS on 12/11/22 for weakness and nausea that had been going on for about three days. She notes that she recently received her COVID vaccine a few days ago (12/8/22). Workup in the ED revealed UTI, NSTEMI, and A fib with RVR. A COVID PCR test also resulted positive. Ultimately patient was admitted 12/11/22 - 12/21/22, with discharge diagnoses including NSTEMI with cardiomyopathy and acute respiratory failure with hypoxia likely due to combination of COVID-19 infection and congestive heart failure, among other discharge diagnoses. During admission, the patient required supplemental oxygen, but was able to be weaned off. Patient is fully vaccinated.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19-2
Symptoms: Cardiac failure congestive, Cardiomyopathy, Laboratory test abnormal, Nausea, SARS-CoV-2 test positive
Clinical narrative: Patient was brought to the ED by EMS on 12/11/22 for weakness and nausea that had been going on for about three days. She notes that she recently received her COVID vaccine a few days ago (12/8/22). Workup in the ED revealed UTI, NSTEMI, and A fib with RVR. A COVID PCR test also resulted positive. Ultimately patient was admitted 12/11/22 - 12/21/22, with discharge diagnoses including NSTEMI with cardiomyopathy and acute respiratory failure with hypoxia likely due to combination of COVID-19 infection and congestive heart failure, among other discharge diagnoses. During admission, the patient required supplemental oxygen, but was able to be weaned off. Patient is fully vaccinated.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19-2
Symptoms: Urinary tract infection
Clinical narrative: Patient was brought to the ED by EMS on 12/11/22 for weakness and nausea that had been going on for about three days. She notes that she recently received her COVID vaccine a few days ago (12/8/22). Workup in the ED revealed UTI, NSTEMI, and A fib with RVR. A COVID PCR test also resulted positive. Ultimately patient was admitted 12/11/22 - 12/21/22, with discharge diagnoses including NSTEMI with cardiomyopathy and acute respiratory failure with hypoxia likely due to combination of COVID-19 infection and congestive heart failure, among other discharge diagnoses. During admission, the patient required supplemental oxygen, but was able to be weaned off. Patient is fully vaccinated.
Age: 21.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acidosis, Acute kidney injury, Agitation, Decreased appetite, Delirium
Clinical narrative: Hospitalization 8/11/22-8/14/22 paranoia, delirium, psychosis, agitated, drug overdose, acidosis, AKI, decreased appetite,
Age: 21.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Overdose, Paranoia, Psychotic disorder
Clinical narrative: Hospitalization 8/11/22-8/14/22 paranoia, delirium, psychosis, agitated, drug overdose, acidosis, AKI, decreased appetite,
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Moderna 2/25/21 Lot# 037K20A;  Moderna 3/25/21 Lot# 011M20A;  Moderna 7/18/22 Lot# 037A22B
Age: 1.25
Sex: F
Vaccine: DTAPIPVHIB
Symptoms: Erythema, Nodule, Skin warm, Swelling
Clinical narrative: Pentacel vaccine was given she woke up the next day with a hot and raised knot in her arm the redness covered her entire shoulder.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Moderna 2/9/21 Lot# 038K20A;  Moderna 3/9/21 Lot# 030A21A
Age: 22.0
Sex: F
Vaccine: RAB, RAB
Symptoms: Dyspnoea, Feeling hot, Flushing, Urticaria
Clinical narrative: FLUSHING/ SOB/ FEELING HOT/ URTICARIA ON UPPER TORSO AND UPPER ARMS
Age: 22.0
Sex: F
Vaccine: RAB, RAB
Symptoms: Allergy to vaccine, Anaphylactic reaction, Blood immunoglobulin E abnormal
Clinical narrative: FLUSHING/ SOB/ FEELING HOT/ URTICARIA ON UPPER TORSO AND UPPER ARMS
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Anticoagulant therapy, Deep vein thrombosis, Pain in extremity, Ultrasound Doppler abnormal
Clinical narrative: Shot 1 was administered in alternate location on 8-3-21.  Shot 2 was administered in another alternate location on 9-14-21.  There were no reactions to either shot.  Around 13 January, I started having calf pain and went to my PCM.  He classified my injury as an inner soleus tear initially.  After the injury worsened and I went to the ER on 3 February, I found out that it was not an injury, rather an exceptional case of DVT.  I started Xarelto on 4 February, and have been on blood thinners since.  I still have a clot in my leg and might need surgery if the clot does not dissolve.  I am due to go back to the doctor to get a follow-up ultrasound in several weeks.  I am completely healthy and work out 6-7 days a week.  I have no other health problems and believe that my DVT was caused by the vaccine.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Deep vein thrombosis, Erythema, Peripheral embolism, Peripheral swelling, Skin warm
Clinical narrative: Ultra Sound found a massive blood clot from my right foot extending to my upper right hip area.  Swollen right foot, right leg warm and red.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Thrombosis, Ultrasound Doppler abnormal
Clinical narrative: Ultra Sound found a massive blood clot from my right foot extending to my upper right hip area.  Swollen right foot, right leg warm and red.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Moderna 3/27/21 Lot# 018B21A;  Moderna 4/24/21 lot# 043B21A
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Pfizer 4/7/21 Lot# Ew0150;  Pfizer 4/28/21 Lot# Ew0162
Age: 23.0
Sex: F
Vaccine: COVID19-2
Symptoms: Syncope
Clinical narrative: syncopy. Patient received Pfizer Covid Bivalent in office today at 11:22 AM, at 11:28 AM patient was at Check-Out and began to appear sluggish. At that time, the patient service representative (PSR) requested assistance with patient. Reporter, the RMA arrived to patient and observed patient as patient began to pass out. Reporter was able to reach patient and help her to the ground. Patient was not injured and was softly laid to the ground. At which time, reported called for the NP who was availble to help with patient and patient began to come to. Patient recovered by 11:29 AM. The NP held patients legs up with patient flat on ground, patient was talking and did not remember fainting. Reporter supported NP staff with providing a cold paper towel to patients forehead. Patient regained color and was set up against the wall at 11:31 AM. At 11:33, patient was assisted in moving to the chair, being monitored. Patient then called family/friend to pick them up. Patient was given bagel and water. Patient denied ever fainting from previous vaccines or blood draws.
Age: 17.0
Sex: F
Vaccine: MENB
Symptoms: Fatigue, Headache, Injection site pain, Oropharyngeal pain
Clinical narrative: Reports headache, fatigue, sore throat, and pain at injection site that began 30 minutes post vaccination.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Cellulitis, Cough, Dyspnoea, Erythema, Fall
Clinical narrative: Hospitalized 8/14/22-8/21/22 fall, foot pain and redness, cough, tachypnea, sepsis, cellulitis, SOB, respiratory failure with hypoxia, PNA,
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pneumonia, Respiratory failure, Sepsis, Tachypnoea
Clinical narrative: Hospitalized 8/14/22-8/21/22 fall, foot pain and redness, cough, tachypnea, sepsis, cellulitis, SOB, respiratory failure with hypoxia, PNA,
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Cold sweat, Dizziness, Headache, Loss of consciousness
Clinical narrative: Pt received Moderna Monovalent Series Dose #1 on 2/8/23. Pt reports dizzy. Upon RN assessment, pt had episode of sycope, weakness, N/V, vitals WDL, A&0x2. Family member stated that pt's LOC was not at baseline. Pt experiencing photophobia, H/A, neck pain, and clammy skin. 911 called at 1732.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Neck pain, Photophobia, Syncope, Vomiting
Clinical narrative: Pt received Moderna Monovalent Series Dose #1 on 2/8/23. Pt reports dizzy. Upon RN assessment, pt had episode of sycope, weakness, N/V, vitals WDL, A&0x2. Family member stated that pt's LOC was not at baseline. Pt experiencing photophobia, H/A, neck pain, and clammy skin. 911 called at 1732.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Abdominal pain, COVID-19, Diarrhoea, Dyspnoea, Headache
Clinical narrative: Patient with history of Crohn's and ulcerative colitis. She was seen in the ED on 12/12/22 with fever, shortness of breath, diarrhea, myalgias, headache, and abdominal pain. A COVID PCR test done in the ED resulted as positive. Ultimately, patient was admitted 12/12/22 - 12/14/22 for COVID-19 infection and hypokalemia. Patient remained on room air during hospitalization and did not require any oxygen or antiretrovirals.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Hypokalaemia, Myalgia, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Patient with history of Crohn's and ulcerative colitis. She was seen in the ED on 12/12/22 with fever, shortness of breath, diarrhea, myalgias, headache, and abdominal pain. A COVID PCR test done in the ED resulted as positive. Ultimately, patient was admitted 12/12/22 - 12/14/22 for COVID-19 infection and hypokalemia. Patient remained on room air during hospitalization and did not require any oxygen or antiretrovirals.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines  Moderna 2/9/21 Lot# 031L20A;  Moderna 3/9/21 Lot# 032M20A;  Moderna 10/27/21 Lot# 076C21A
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Pfizer 2/22/22 LOt# FJ6369;  Pfizer 3/17/22 LOt# FK9894; Pfizer 7/25/22 Lot# FN2908;
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Alcohol intolerance, Anxiety, Blood pressure increased, Blood test, Chest pain
Clinical narrative: I woke up with a heart rate over 190 bpm. Started getting painful, sharp PVC's (diagnosed in 2022). My PVC's were around 20-40 a day at first then grew to 5k to 10k per day, so every 5 to 10 beats would skip. My blood pressure at times was 190/125. I would rush to the ER for them to say nothing was wrong except my bp was up. I had no clue there was vaccine injury compensation available or else I would have applied. I had edema in my right leg (diagnosed 7/21). Migraines for the first time in my life lasting for weeks. Sudden chest pains that almost knocked me to the ground. Would go get blood checked and I had no signs of heart attack. Shooting pains through my right temple. The PVC's come and go. I'll go weeks without one sometimes but when they're bad I want to commit suicide sometimes just to be done with the torture.  I can't drink coffee or any alcohol. Eat steak, bacon, cheese, too much milk, etc. Any fattening foods make the PVC's worse. Caffeine, chocolate, and sleeping medicine all make the PVC's much worse.  I am doing a tremendous amount of self care, dieting, and exercise plus supplements to keep the PVC's in check but I'll get bad bouts of it where I'll get 10k+ PVC's a day